UroNova Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

UroNova Pharmaceuticals, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include URONOVA and VABRINTY. The owner is based in Buffalo Grove, IL.

485 Half Day Road, Suite 400

Buffalo Grove, IL 60089

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

URONOVA
URONOVA
Registered 2025
URONOVA
URONOVA
Registered 2025
VELKEE
VELKEE
Pending 2025
VABRINTY
VABRINTY
Registered 2025
TELUXXY
TELUXXY
Pending 2025
ZOTKIP
ZOTKIP
Abandoned 2025

Trademark Classifications

UroNova Pharmaceuticals, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does UroNova Pharmaceuticals, Inc. have?

UroNova Pharmaceuticals, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 1 abandoned.

What trademark classes does UroNova Pharmaceuticals, Inc. file in?

UroNova Pharmaceuticals, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are UroNova Pharmaceuticals, Inc.'s most well-known trademarks?

UroNova Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as URONOVA and VABRINTY. These are among 3 currently registered trademarks in the portfolio.

What is UroNova Pharmaceuticals, Inc.'s trademark registration success rate?

UroNova Pharmaceuticals, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.